We hypothesize that radiation followed by or concurrent with immunotherapy, rather than starting with immunotherapy, will lead to optimal results by exposing tumor antigens and utilizing radiation-induced increase in PD-L1 expression to fuel immunotherapy response (56, 62). This evidence concerns the gene CD274 and neoplasm.